Androgen deprivation therapy (ADT) is the mainstay regimen in patients with androgen-
dependent prostate cancer (PCa). However, the selection of androgen-independent cancer …

Simple Summary Advanced prostate cancer has a higher mortality rate at diagnosis
compared to localised prostate cancer. As such, it is critical to understand the mechanisms …

Prostate cancer is a major male malignancy in many sub-Saharan countries in Africa.
Because of resource limitations, screening, early detection, diagnosis, and curative …

Primary prostate cancer (PC) progresses to castration-resistant PC (CRPC) during androgen
deprivation therapy (ADR) in early stages of prostate cancer. Thus, rather than blocking the …

Objective: Real-word data on long-acting luteinizing hormone-releasing hormone (LHRH)
agonists in Chinese patients with prostate cancer are limited. This study aimed to determine …

The aberrant activation of HER2 has a pivotal role in bone metastasis implantation and
progression in several tumor types, including prostate cancer (PC). Trastuzumab and other …

Introduction Relugolix is the first oral gonadotrophin-releasing hormone (GnRH) receptor
antagonist. Based on the phase III HERO trial results, relugolix received Food and Drug …

Background Globally, prostate cancer is a common disease among men. However, limited
epidemiological data exists regarding prostate cancer in Tanzania. Consequently, there is …

Abstract The Sir Stanley Peart Essay Competition is an annual event run by the British and
Irish Hypertension Society to encourage Early Career Researchers to continue the ethos of …

To gain insights on the diverse practice patterns and treatment pathways for prostate cancer
(PC) in India, the Urological Cancer Foundation convened the first Indian survey to discuss …